Barone J A, Weisman R, Mangione R A, Goldfrank L R
Clin Pharm. 1984 May-Jun;3(3):281-4.
Serum lidocaine concentrations were determined following subcutaneous administration for local anesthesia in the management of lacerations in the emergency room setting. Thirty patients received doses of lidocaine hydrochloride 1% solution ranging from 10 to 300 mg. Venous blood samples were drawn 15, 30, 45, and 60 minutes after lidocaine administration. Serum lidocaine determinations were made using an immunoassay system and verified by gas chromatography. There was no evidence of lidocaine absorption from the subcutaneous injection sites. There were no detectable concentrations of lidocaine in any of the patient blood samples. The absorption characteristics of subcutaneously administered lidocaine appear to be altered in traumatized tissue.
在急诊室环境下,对用于伤口缝合局部麻醉的利多卡因皮下给药后的血清浓度进行了测定。30例患者接受了1%盐酸利多卡因溶液,剂量范围为10至300毫克。在利多卡因给药后15、30、45和60分钟采集静脉血样。血清利多卡因测定采用免疫分析系统,并通过气相色谱法进行验证。没有证据表明利多卡因从皮下注射部位吸收。在任何患者血样中均未检测到利多卡因浓度。创伤组织中皮下注射利多卡因的吸收特性似乎发生了改变。